INTERNATIONAL STEM CELL CORPORATION (ISCO) Gross margin 2016–2025
INTERNATIONAL STEM CELL CORPORATION (ISCO) gross margin by fiscal year — reported gross profit divided by reported revenue.
55.7%FY2025 · since FY2016: 72.9% → 55.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 55.7% | -2.9 pp |
| FY2024 | 58.6% | -0.6 pp |
| FY2023 | 59.2% | -0.9 pp |
| FY2022 | 60.0% | +0.9 pp |
| FY2021 | 59.1% | -1.9 pp |
| FY2020 | 61.0% | +2.5 pp |
| FY2019 | 58.5% | -4.8 pp |
| FY2018 | 63.3% | -8.2 pp |
| FY2017 | 71.5% | -1.3 pp |
| FY2016 | 72.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ISCO financial trends
ISCO RevenueISCO Net incomeISCO Net marginISCO Gross profitISCO Operating incomeISCO Operating marginISCO Operating cash flowISCO Free cash flowISCO Capital expendituresISCO Return on equityISCO Stock buybacksISCO Dividends paidISCO Total assetsISCO Total liabilitiesISCO Shareholders’ equityISCO overview →